Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 801 - 850 out of 6,631

Document Document Title
WO2004108746A3
The present invention discloses compounds of formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions com...  
WO/2005/030785A2
The invention relates to novel compounds of 5-thioxylose and, preferably, 5-thioxylopyranose-type derivatives. The invention also relates to the method of preparing said compounds and to the use of same as an active principle in medicame...  
WO/2005/030233A1
An active oxygen scavenging agent; and a process for producing the same. In particular, an active oxygen scavenging agent comprising as an active ingredient a product of decomposition of anthocyanin pigment derived from acerola; and a pr...  
WO2005021566A3
The invention relates to glucopyranosyloxy-pirazoles of formula (I), wherein R1 to R6 and R7a, R7b and R7c are defined in the claim 1, to the tautomers, stereoisomers, mixtures and the salts thereof, in particular the salts which are phy...  
WO/2005/030227A1
The present invention discloses compounds of formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof, which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions com...  
WO/2005/028493A1
Antimicrobial compounds are provided having the formula (Q): as well as tautomers, stereoisomers, pharmaceutically acceptable salts, esters or prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating b...  
WO/2005/028630A2
Disclosed herein are methods and compositions for modulation of gene expression, with single-gene specificity, in a human sized genome.  
WO/2005/027828A2
This invention features a compound of the following formula: T-(-L-C)m, T is a transportophore, L is a bond or a linker having a molecular weight up to 240 dalton, C is a non-antibiotic therapeutic agent, and m is 1, 2, 3, 4, 5, 6, 7, or...  
WO2004094449A8
The present invention relates to new compounds represented by Formula (I); wherein M represents a macrolide subunit of the substructure II, Formula (II); L represents the chain of the substructure III, Formula (III); D represents the ste...  
WO/2005/027622A1
It is intended to provide a flower color crossing method whereby a specific flower color is passed to the next generation of delphinium and a flower color crossing method whereby a dichromatic flower color is passed to the next generatio...  
WO/2005/028492A1
The invention relates to a crystalline compound of 4'-demethyl-4'-phosphate-2',3'-bispentafluorophenoxyacetyl-4 ',6'-ethylidene-β-D-epipodophyllotoxin glucoside in its free form or solvated with ethanol, advantageously provided in the f...  
WO/2005/025490A2
A novel family of cyclic polyene natural products isolated from marine actinomycete strain CNQ 140 is provided. This novel strain of actinomycetes was obtained from a previously unstudied population of marine actinomycetes that reside in...  
WO2004108744A3
The present invention relates to novel azalides and azaketolides having antimicrobial activity, methods for their preparation, pharmaceutical compositions containing the compounds and methods of treating microbial infections with the com...  
WO/2005/021567A1
The present invention relates to a process for regioselective O-alkylation of macrolide and azalide derivatives, specifically 11-0-alkyl derivatives represented by formula (I) (1) R1 wherein A is 14-membered macrolide derivative and 15-m...  
WO/2005/021566A2
The invention relates to glucopyranosyloxy-pirazoles of formula (I), wherein R1 to R6 and R7a, R7b and R7c are defined in the claim 1, to the tautomers, stereoisomers, mixtures and the salts thereof, in particular the salts which are phy...  
WO2005000863A3
The present invention discloses compounds of formula (I), or pharmaceutically acceptables salts, esters, or prodrugs thereof, which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions co...  
WO/2005/018577A2
Compounds of formula (I) and R1, R 2 R 3 and R 4 are as defined herein, are prokinetic agents and can be used to treat disorders of gastric motility.  
WO/2005/018576A2
Compounds having the structure of formula I: wherein R1,R2,R3, R4, R5, and R6 are as defined herein, are prokinetic agents and can be used to treat disorders of gastric motility.  
WO/2005/019238A1
Compounds represented by the general formula (1) or pharmaceutically acceptable salts thereof, effective in the prevention and/or treatment of infections with microbes: (1) (a) wherein R1 is hydrogen or straight-chain C1-6 alkylcarbonyl;...  
WO2004108745A3
The present invention discloses compounds of formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions com...  
WO/2005/016851A1
The invention relates to novel molecules and libraries thereof as well as methods for their production. Methods of producing the novel molecules include a. cleaving one or more of starting molecules into molecular subunits ; and b. assem...  
WO2004080391A3
This invention relates to novel macrolides, to the preparation of novel macrolides, to the use of such novel macrolides for preventing, treating, or ameliorating various conditions, and to the use of such novel macrolides as antibacteria...  
WO/2005/012322A1
A process for producing erythromycin A 11,12-cyclic carbonate (compound (II)) from erythromycin A (compound (I)), which is shown by the reaction scheme, [Chemical formula 1] (I) → (II) the process comprising reacting erythromycin A wit...  
WO/2005/012243A2
Substituted indole-O-glucosides, compositions containing them, and methods of using them, for example for the treatment of diabetes and Syndrome X are disclosed.  
WO/2005/012321A1
A compound of the formula (I): wherein Ring A and Ring B are (1) Ring A is an optionally substituted unsaturated monocyclic heterocyclic ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionall...  
WO2004096823A3
Antimierobial ketolide compounds are provided having the formula (A), as well as pharmaceutically acceptable salts, esters or prodrugs thereof, pharmaceutical compositions comprising such compounds, methods of treating bacterial infectio...  
WO/2005/011592A2
Substituted indazole-O-glucosides, compositions containing them, and methods of using them, for example for the treatment of diabetes and Syndrome X are disclosed.  
WO/2005/012242A2
This invention relates to to substituted benzimidazole-O-glucosides, benztriazole-O-glucosides, and benzimidazolone-O-glucosides, compositions containing them, and methods of using them, for example, for the treatment or prophylaxis of d...  
WO/2005/012318A2
This invention relates to substituted fused heterocyclic C-glycosides, compositions containing them, and methods of using them, for example, for the treatment or prophylaxis of diabetes and Syndrome X.  
WO/2005/010019A1
Crystalline 6-N-pyridylmethylamino-12,13-dihydro-2,10 -dihydroxy-12-β-D-glucopyranosyl-5H-indolo[2,3-a]pyrrolo[3, 4-c]carbazole-5,7(6H)-diones in the form of the free bases as represented by the general formula (I), pharmaceutically acc...  
WO/2005/010018A1
6-N-Pyridylmethylamino-12,13-dihydro-2,10-dihydroxy- 12-β-D-glucopyranosyl-5H-indolo[2,3-a]pyrrolo[3,4-c]carba- zole-5,7(6H)-dione free bases (I) in the form of crystals; pharmaceutically acceptable salts of the same; or solvates thereo...  
WO/2005/010017A1
A compound represented by the formula [I] (wherein R represents unsubstituted pyridyl, furyl, or thienyl; m is an integer of 1 to 3; G represents ß-D-glucopyranosyl; and the hydroxy substituents on the indolopyrrolocarbazole ring are lo...  
WO/2005/010020A1
A compound represented by the formula [I] (wherein R represents unsubstituted pyridyl, furyl, or thienyl; m is an integer of 1 to 3; G represents β-D-glucopyranosyl; and the positions of the hydroxy substituents on the indolopyrrocarbaz...  
WO/2005/009398A2
The invention relates to Tetracyclic Benzamide Derivatives; compositions comprising a Tetracyclic Benzamide Derivative; and methods for treating or preventing an inflammatory disease, a reperfusion disease, an ischemic condition, renal f...  
WO/2005/007666A1
Disclosed is a method for producing a compound represented by the following formula (I): (I) (wherein R1 is a hydrogen atom or a lower acyl group, R2 represents a hydrogen atom, a lower acyl group or the like, R3 represents a lower alkyl...  
WO/2005/003112A1
A flavonoid solubilization agent capable of solubilizing to a high degree flavonoids such as isoflavon, baicalin, rutin and naringin whose solubility is generally low; and a method of effecting the above solubilization. Flavonoids can be...  
WO/2005/003146A1
The present invention relates to the C-glycosylisoflavones having alkylaminoalkoxyl substituent, the pharmaceutic salt thereof, and the preparation thereof, and to the pharmaceutical compositions comprising effective amount of general fo...  
WO/2005/003144A1
A direct, single step process for preparing a semi-synthetic antibiotic azithromycin dihydrate (non-hygroscopic) is provided, by in situ reductive N-methylation of azaerythromycin A and subsequent crystallization from a mixture of aceton...  
WO/2005/003145A1
Provided are compositions and formulations containing an SZY extract or its active ingredients, loganin, morroniside, and cornuside. Also disclosed is a method of treating pain, autoimmune diseases, and inflammation using such compositio...  
WO2004092736A3
The invention relates to derivatives of azithromycin, processes for the manufacture thereof and pharmaceutical compositions thereof preferably together with azithromycin.  
WO/2005/000860A2
Compositions and methods for treatment of disease with acetylated disaccharides and analogs thereof are provided.  
WO/2005/000319A1
It is intended to provide a skin composition for external use that contains an ascorbic acid derivative having a high stability, being continuously usable in vivo, having a strong antioxidant effect and showing little skin irritation and...  
WO/2005/000863A2
The present invention discloses compounds of formula (I), or pharmaceutically acceptables salts, esters, or prodrugs thereof, which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions co...  
WO2004064715A3
Isolated immunomodulatory (e.g. immunostimulatory) polyhydroxlated pyrrolizidine compounds having the formula (I), wherein R is selected from the group comprising hydrogen, straight or branched, unsubstituted or substituted, saturated or...  
WO/2004/110255A2
The present invention relates to novel antineoplastic agents and cancer diagnostic agents that specifically target neoplastic cells via the GLUT transportation system. More specifically, the invention relates to conjugates of 2­-deoxygl...  
WO/2004/111070A1
A compound of formula (I) wherein the bond between carbon atoms 22 and 23 may be a single or a double bond; R1 is C1-C12alkyl, C3-C8cycloalkyl, or C2-C12alkenyl; R2 and R3 are, for example, independently of each other hydrogen, C1-C12alk...  
WO2004096822A3
Antimicrobial macrolide and ketolide compounds are provided having formulas (XII), as well as pharmaceutically acceptable salts, esters or prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bacte...  
WO/2004/108745A2
The present invention discloses compounds of formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions com...  
WO/2004/108744A2
The present invention relates to novel azalides and azaketolides having antimicrobial activity, methods for their preparation, pharmaceutical compositions containing the compounds and methods of treating microbial infections with the com...  
WO/2004/108746A2
The present invention discloses compounds of formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions com...  

Matches 801 - 850 out of 6,631